Skin Lightening With Emblica™ (O/W) MDA-A-155-01

Susonity
Phase
Product
INCI Name
Supplier
Volume
A

RonaFlair® Boroneige® SF-3

BORON NITRIDE

1

5.00

Tego Care 215

GLYCERYL STEARATE, CETEARETH-15

2

2.50

Cetiol V

DECYL OLEATE

3

7.00

Mirasil DM 350

DIMETHICONE

4

0.50

Lanette 18

STEARYL ALCOHOL

3

2.00

Carbopol ETD 2050

CARBOMER

5

0.20

Isopropyl Palmitate

Isopropyl Palmitate

3

7.00

B

Glycerol 85%

GLYCERIN, AQUA (WATER)

1

3.00

Titriplex® III

DISODIUM EDTA

1

0.10

Water, demineralized

63.20

C

Emblica™

PHYLLANTHUS EMBLICA FRUIT EXTRACT

1

2.00

Preservatives

qs

Water, demineralized

5.00

D

Sodium Hydroxide, 10%

AQUA (WATER), SODIUM HYDROXIDE

1

1.50

Preparation:

Prepare phase A without Boroneige SF- 3. Heat phases A and B separately to 80°C. Disperse Boroneige SF-3 into the oil phase A with a dissolver stirrer. Add phase A to phase B while stirring. Disperse Emblica in water and add phase C to A/B under 40°C. Neutralize with phase D. Homogenize. Add phases E and cool down while stirring.

Notes:

pH value (23°C) : 5.40Viscosity : 40 000 mPa.s (Brookfield DV-II+, Helipath, spindle C, 10 rpm, Helipath) at 23°CAppearance: beige emulsion

(1) Merck KGaA, Darmstadt, Germany / EMD Chemicals (2) Evonik Goldschmidt GmbH (3) BASF AG (4) Rhodia GmbH (5) Lubrizol (6) Schülke & Mayr GmbH

Disclaimer

While every effort has been made to reproduce these formulations correctly, the Publisher of this website cannot accept any liability for the information presented. All formulations are provided in good faith, but no warranty is given as to accuracy of information or results, or suitability for a particular use, nor is freedom from patent infringement to be inferred. Formulations are offered solely for consideration by the participating manufacturers. Continued use of this web site infers acceptance of this disclaimer.

Latest Issues

NYSCC Suppliers' Day 2026

Javits Center, New York
19 - 20 May

in-cosmetics Korea 2026

COEX, Seoul
1 - 3 July 2026